GSK plc Files Director/PDMR Shareholding Report
Ticker: GSK · Form: 6-K · Filed: Apr 20, 2026 · CIK: 0001131399
Sentiment: neutral
Topics: insider-trading, disclosure, sec-filing
TL;DR
GSK filed a 6-K on 4/20/26 detailing director and PDMR shareholdings.
AI Summary
On April 20, 2026, GSK plc filed a Form 6-K, reporting a Director/PDMR Shareholding. The filing includes details about shareholdings of directors and persons discharging managerial responsibilities within the company. The mailing and business addresses are both listed as 79 New Oxford Street, London, United Kingdom, WC1A 1DG.
Why It Matters
This filing provides transparency into the stock ownership of key company insiders, which can be an indicator of their confidence in the company's future performance.
Risk Assessment
Risk Level: low — This is a routine disclosure of director and PDMR shareholdings, which is standard for publicly traded companies and does not indicate any new or unusual risks.
Key Players & Entities
- GSK plc (company) — Filer of the report
- 0001131399 (company) — CIK number for GSK plc
- 0001654954-26-003726 (document) — SEC Accession Number for the filing
- 2026-04-20 (date) — Filing date and period of report
- 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG (address) — Mailing and Business Address for GSK plc
FAQ
What type of information is disclosed in this Form 6-K filing?
This Form 6-K filing discloses Director/PDMR Shareholding information.
What is the accession number for this SEC filing?
The SEC accession number for this filing is 0001654954-26-003726.
When was this filing accepted by the SEC?
This filing was accepted by the SEC on April 20, 2026.
What are GSK plc's mailing and business addresses as listed in the filing?
GSK plc's mailing and business addresses are both listed as 79 New Oxford Street, London, United Kingdom, WC1A 1DG.
What is the CIK number for GSK plc?
The CIK number for GSK plc is 0001131399.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 20, 2026 regarding GSK plc (GSK).